---

Highlights for Feb 2016:

1. With free cash flow of about USD 400 million, Dr. Reddy's are scouting for acquisition opportunities, globally
2. Lupin eyes acquisitions to achieve USD 5 Bn by 2018; remains committed to emerging markets
3. Cipla completed acquisition process of two companies, InvaGen and Exela
4. Private equity funds, Baring Asia, Capital International and Brain Capital in talks to buy stake in SRL Diagnostics
5. MedGenome acquires Lifecode Health assests and its CLIA certified lab in Foster City, CA to expand its genomic services to biotech and pharma companies in the US
6. Wipro Acquires US-based HealthPlan For US$460 Million
7. India’s pharma market to skyrocket from $20 bn in 2015 to $55 bn by 2020 (CAGR of 22.4%), says research and consulting firm GlobalData.
8. The medical devices space in India will see impressive expansion, rising from $10.4 billion in 2014 to reach $17.6 billion by 2020, representing a robust CAGR of 9.4 percent, according to research and consulting firm GlobalData

For more such news and updates, please join our Group "Global Life Science Business in India" on LinkedIn.

Aagami Updates:

1. Feb 2016 - Aagami participated in Bio Asia 2016 in Hyderabad, India, representing several clients
2. Aagami CEO to bring a client company to India in March 2016 for finalizing more partnerships with Top India based companies.